BETA – unverified. Reference only. Verify with current labeling & facility policy. Not a substitute for clinical judgment. No patient info (PHI) here. Details
‹
escitalopram

Lexapro

SSRI⚠ Unverified beta content

At a glance

Class
Selective serotonin reuptake inhibitor
Black box
  • ⚠ Suicidal thoughts and behaviors
Key monitoring
  • Suicidality / mood / behavior
Usual adult dose
MDD / GAD: 10–20 mg/day
Call provider / escalate if
Thoughts of suicide or self-harm, or worsening mood • Fainting, palpitations, irregular heartbeat • Serotonin syndrome signs (agitation, fever, sweating, tremor, stiffness, diarrhea)

Boxed warning

  • Suicidal thoughts and behaviors: antidepressants increase the risk in children, adolescents and young adults (to age 24) with major depression and other psychiatric disorders. Monitor closely, especially at start and with dose changes.

Other serious warnings

  • Serotonin syndrome
  • Dose-related QT prolongation (less than citalopram; caution with risk factors)
  • Bleeding risk
  • Hyponatremia/SIADH
  • Activation of mania
  • Discontinuation syndrome

Sources: FDA label (DailyMed): LEXAPRO (ESCITALOPRAM) TABLET, FILM COATED LEXAP

  • Suicidality / mood / behavior
    When: Every contact; closely early & after dose changes
  • ECG / QTc
    When: Baseline if risk factors
    If risk factors; correct K/Mg first
  • Sodium
    When: If at risk or symptomatic

Sources: FDA label (DailyMed): LEXAPRO (ESCITALOPRAM) TABLET, FILM COATED LEXAP